The addition of bacterial lipopolysaccharide (LPS) from Escherichia coli 0111:B4 to human monocytemacrophages cultured in serum results in suppression of scavenger receptor activity. The present studies were performed to examine if the effect on scavenger receptor activity was mediated by LPS alone or by LPS in association with lipoproteins. Radioiodinated LPS (12,I-LPS) was added to human plasma in vitro and to normal and hyperlipidemic rabbit plasma in vitro and in vivo to determine the distribution of 12'I-LPS among the lipoprotein classes. It was found that all lipoprotein classes bound LPS in direct proportion to their plasma cholesterol concentration. LPS alone was compared to LPS bound to low density lipoprotein (LDL), high density lipoprotein, or reductively-methylated LDL for their abilities to suppress scavenger receptor activity in monocytemacrophages in lipoprotein-free serum. Only LPS bound to LDL (LPS-LDL) demonstrated an effect similar to that observed when LPS was added to cells in serum. Either unlabeled LDL or unlabeled LPS-LDL complexes competed with the uptake of 12sI-LPS-LDL complexes, which appeared to proceed by receptor-mediated endocytosis. In contrast to the uptake of 12SI-LDL, the uptake of '2sI-LPS-LDL by cultured monocyte-macrophages was not followed by its hydrolysis and the release of its radioactive degradation products into the medium. The association of LPS with lipoproteins was very stable and appeared to be mediated by a lipid-ipid interaction.
It was initially shown by Ulevitch and Johnston that incubation of bacterial lipopolysaccharide (LPS) with serum could modify its endotoxic properties and produce a shift in the hydrated density of the LPS (1) . Subsequently, it was demonstrated that lipoproteins in the serum were able to bind LPS (2) (3) (4) . These studies of lipoprotein-LPS interactions have focused on the role of high density lipoproteins (HDL) and have utilized rats or rabbits as experimental models, species in which HDL carries most of the plasma cholesterol.
Studies from this laboratory (5) found that, in addition to HDL, low density lipoproteins (LDL) markedly reduced the cytotoxic effects of LPS added to bovine aortic endothelial cell cultures compared to cells that did not have lipoproteins present in the medium. These results have recently been confirmed by others (6) .
We have shown (7) that LPS added to human monocytemacrophages cultured in serum resulted in suppression of scavenger receptor activity. It was not determined, however, if this suppression was mediated by LPS alone or by LPS associated with serum lipoproteins. In the present investigation, we studied the interaction between LPS and plasma lipoproteins. We demonstrate that (i) all major lipoprotein classes bind LPS in the blood in direct proportion to their plasma cholesterol concentration; (ii) the association of LPS with lipoproteins is remarkably stable; (iii) a lipid-lipid interaction appears to account for the association ofLPS with lipoproteins; (iv) the uptake of LPS-LDL complexes proceeds by apolipoprotein B/E receptor-mediated endocytosis and results in suppression of scavenger (malondialdehyde altered-LDL) receptor activity.
MATERIALS AND METHODS
Materials. The LPS (from Escherichia coli strain 0111:B4) and chloramine-T were purchased from Sigma. Sepharose CL-2B was purchased from Pharmacia. p-Hydroxymethylbenzimidate (Wood's reagent) was purchased from Pierce Biochemicals. Polyvalent E. coli antiserum was purchased from Baltimore Biological Laboratories, Microbiology Systems (Cockeysville, MD). All other supplies and reagents were obtained from sources as reported (7).
Human Subjects. Normal fasted subjects were recruited from the staff and student body at UCLA. Informed consent was obtained in writing from each person.
Rabbits. Normal New Zealand White (NZW) male rabbits, NZW rabbits fed a 2% cholesterol diet, NZW rabbits infused with 160 mg of rabbit LDL protein per kg of body weight, or Watanabe heritable hyperlipidemic (WHHL) rabbits were used in these studies (8) . All rabbits were fasted for 24 hr before experiments were begun.
Separation and Culture of Cells. Monocytes were prepared by counterflow centrifugation, classified, and cultured, and their viability was determined as described (9) .
Lipoprotein Isolation and Preparation. Very low density lipoproteins (VLDL) (density < 1.006 g/ml), LDL (density = 1.019-1.063 g/ml), and HDL (density = 1.063-1.21 g/ml) were isolated by the method of Havel et al. (10) from either rabbit or human plasma after a fast. Lipoproteins were radiolabeled as described (11, 12) . Malondialdehyde-treated LDL and reductively methylated LDL (ReMe-LDL) were prepared as described (13) .
Column Chromatography. Sepharose CL-2B was used to separate LDL, LPS, and LPS-LDL complexes. Chromatography was carried out with 1-ml sample aliquots containing 1 mg of LPS in lipoprotein-deficient serum or 1 mg of LDL or LPS-LDL protein applied to a 0.9 x 60 cm column. The samples were eluted in 0.15 M NaCl/10 mM phosphate/ 0.01% EDTA, pH 7.4, at 230C and at a flow rate of 20 ml/hr.
The void volume was 36.3 ml, and fractions of 0.5 ml were collected. LPS Preparation. The LPS used in these studies was modified by p-hydroxymethylbenzimidate by the method of Ulevitch (14) . The derivatized LPS was radiolabeled as described (14) . Ulevitch has previously demonstrated that these procedures do not alter the biologic properties of LPS (1) (15) .
Prior to initiating studies, the cells were washed three times with 1-ml volumes of Dulbecco's modified Eagle's medium containing 10 mM Hepes (pH 7.4) (medium C). Radioactive lipoproteins were added to the cells in medium C supplemented with 25 mM NaHCO3 and glucose at 2 mg/ml (medium D).
The proteolytic degradation of 125I-LDL and 125I-labeled malondialdehyde-treated LDL was measured as acid-soluble radioactivity as described (9, 16) . For studies measuring cell-associated radioactivity, the cells were sequentially washed four times with 1 ml of phosphate-buffered saline Gibco Laboratories (Chagrin Falls, OH) containing 0.2% bovine serum albumin and once with 1 ml of phosphatebuffered saline; the first wash was allowed to sit 10 min before proceeding with the remaining washes in rapid succession (9) . Each well then received 0.75 ml of 0.1 M sodium hydroxide; after 30 min at 20°C, the cellular extract was quantitatively transferred to vials for determination of radioactivity. Wells without cells were treated identically to serve as controls.
RESULTS

Distribution of 125I-LPS among the Lipoprotein Fractions.
Incubation of plasma from normal humans with 125I-LPS resulted in most ofthe 125I-LPS partitioned primarily between LDL and HDL (Table 1) . When plasma from NZW rabbits was incubated with 1251-LPS, the lipoprotein fraction associated with the most 125I-LPS was the HDL. Since the majority of plasma cholesterol is contained in the HDL fraction in NZW rabbits, we determined if incubation of 1251-LPS with plasma from rabbits that have elevated levels of other lipoproteins would result in a different distribution. In contrast to NZW rabbits, most of the 125I-LPS in plasma from WHHL and cholesterol-fed rabbits was associated with VLDL and LDL, the major cholesterol-containing lipoproteins of these rabbits.
Similar results were found when 125I-LPS was injected into rabbits and the plasma was removed and fractionated ( VLDL and LDL fractions, as was observed in the in vitro experiments (Table 1) . We conclude that the distribution of LPS in the blood is determined by the concentration of the cholesterol-rich lipoprotein(s) present in the plasma.
Interaction of LPS-Lipoprotein Complexes with Monocyte-Macrophages. We had shown in an earlier study (7) that incubation of human monocyte-macrophages with 10-100 ng of LPS per ml of serum medium inhibited the expression of scavenger receptor activity. It was not known, however, if LPS exerted its effects by direct uptake by the cell or if the effect was mediated by uptake of LPS complexed with lipoproteins. To test this, "I51-LPS was incubated with lipoproteins to determine by radioactivity the content of LPS associated with the lipoproteins in the complexes. Fig. 1 demonstrates that addition of increasing amounts of I-LPS-LDL that contained 10-100 ng of LPS per ml to cells in lipoprotein-deficient serum produced a progressive suppression of scavenger receptor activity as assayed by degradation of endocytosed malondialdehyde-treated LDL. This effect was not seen when the same amount of LPS was added in a complex with either ReMe-LDL or HDL. Moreover, there was only a 38% suppression when LPS was added directly to lipoprotein-deficient serum. The protein content of the cells and their viability were not different whether 125I-LPS-LDL, 125I-LPS-ReMe-LDL, 125I-LPS-HDL, or LPS alone was added. These data indicate that the 125I-LPS-LDL produced a biologic response similar to that previously shown for unlabeled LPS added to serum (7) . Fig. 2 shows that the uptake of 125I-LPS-LDL by monocyte-macrophages could be suppressed by unlabeled ity from 125I-LDL progressively increased in the medium and decreased in the cells within the same period of time.
Evidence for LPS-Lipoprotein Association. The molecular mass of E. coli 0111:B4 LPS has been reported to be 1 MDa (17), whereas LDL has been reported as having a molecular mass of 2-3 MDa (18) . To demonstrate that the "2I being measured and traced in these studies was indeed linked to LPS-lipoprotein complexes, the radioactive compounds were subjected to gel filtration (Fig. 4) . The fraction from WHHL plasma with a density of 1.019-1.063 g/ml (the LDL fraction) contained a broad spectrum of particles. However, after incubation with LDL in the lipoprotein-deficient fraction of serum, there was a shift in the distribution of the radioactivity from smaller (125I-LPS) to larger particles (Fig.   4) , consistent with the formation of 125I-LPS-LDL complexes. As a further means of identification, we used the ring (interfacial) test (19) to immunologically determine the presence of LPS in the '"I-LPS-LDL complex. A precipitin ring formed at the interface between the layer containing the 125I-LPS-LDL complex and an antiserum to E. coli 0111:B4, confirming the presence of LPS in the radioiodinated complex. No precipitin ring was seen when LDL alone was tested. The data from Fig. 4 together with the shift in density of 125I-LPS from >1.21 g/ml (see below) to 1.019-1.063 g/ml upon incubation with LDL in lipoprotein-deficient serum and the immunologic proof that this fraction contained LPS provide strong evidence that 125I-LPS associates with LDL to form I251-LPS-LDL complexes.
Characteristics of the LPS-Lipoprotein Interaction. Reductive methylation of LDL did not affect the association of 125I-LPS with the lipoprotein. Upon ultracentrifugal fractionation, 75% of the radioactivity was isolated in the fraction with a density of 1.019-1.063 g/ml whether ReMe-LDL or native LDL was incubated with 1251-LPS in lipoproteindeficient serum. When, however, 125I-LPS, with a reported density of 1.44 g/ml (2), was incubated without lipoproteins present in the mixture, 99.6% of the radioactivity was found in the fraction with a density of >1.21 g/ml upon reisolation. More than 95% of the radioactivity from 125I-LPS-LDL was extracted into chloroform/methanol as opposed to that from 125I-LDL, of which <2% was extracted into chloroform/ methanol. These results suggest that a lipid-lipid interaction accounts for the association of LPS with lipoproteins, as has injected intravenously into a WHHL rabbit, and 3 hr later the blood was withdrawn for ultracentrifugal isolation of the 15I-LPS-LDL complexes. LDL was isolated from a sibling WHHL rabbit and radioiodinated. Samples were applied and eluted as described.
been suggested for the interaction of LPS with cell membranes (20) .
Stability of the LPS-Lipoprotein Complex. 125I-LPS-LDL
was prepared by in vitro incubation and was subsequently incubated with plasma, and the plasma was fractionated by ultracentrifugation. Ninety-one percent of the radioactivity remained associated with the fraction ofdensity < 1.063 g/ml. 125I-LPS-LDL prepared by in vitro incubation also was injected into a rabbit, and after 3 hr the plasma from the rabbit was ultracentrifugally fractionated. Eighty-nine percent of the plasma radioactivity remained associated with the fraction of density <1.063 g/ml. In other experiments 1251. LPS-LDL complexes were isolated from rabbit plasma by ultracentrifugation 3 hr after the intravenous injection of 1 mg of 125I-LPS. The 125I-LPS-LDL complexes were then incubated with normal or WHHL rabbit plasma in vitro for 6 hr. Upon subsequent ultracentrifugation, more than 90% of the plasma radioactivity remained associated with the LDL fraction. These experiments demonstrate that, once the 125I-LPS-LDL complexes are formed, they are remarkably stable.
DISCUSSION
Our results demonstrate that LPS binds to the plasma lipoproteins, possibly through a lipid A-phospholipid association (20) , forming an LPS-lipoprotein complex. This is a stable complex that persists despite the high salt concentrations, the high gravitational forces encountered in ultracentrifugation, and the possible effects of enzymes present in the plasma. The The "response to injury" hypothesis of atherosclerosis has focused on the effects of chemical agents on cells (22) . Various toxins, lipoproteins, viruses, high plasma homocystine levels, or immunological injury are among the possible factors that could lead to the development of the lipid-filled lesion (22) . LPS is a naturally occurring toxin that could bind to LDL intravascularly and be transported across the endothelium as a complex, independent of the LDL receptor (23) . This complex does not appear injurious to endothelial cells (5, 6) . Once across the endothelium, the LPS-lipoprotein complex may be taken up by receptormediated endocytosis in cells such as macrophages or smooth muscle cells, or it may interact with glycosaminoglycans and remain in the artery wall (22) . Recently, it has been shown that bacterial LPS from E. coli are retained by macrophages in spite of the degradation of the E. coli bacterium itself (24) . The retention of LPS may have direct effects upon the cells of the arterial wall or indirect effects such as the release of factors that promote proliferation or chemotaxis. In contrast to LDL, HDL is not retained in the artery wall (25) . The HDL/LDL ratio has been found to be an important predictor of atherosclerosis (26) . One explanation could be that LPS bound to HDL would not be retained in the artery wall, but LPS bound to LDL or other apolipoprotein B-containing lipoproteins may be retained in the artery wall and may initiate the atherosclerotic reaction.
